| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/15/2004 | US20040009891 Method and composition for treating obesity by targeting cathepsin |
| 01/15/2004 | US20040009890 Structure-based design of a drug that can act as an inhibitor of at least two different biological entities using computer modeling; useful for designing HIV protease inhibitors and antineoplastic agents and where drug resistance may exist. |
| 01/15/2004 | US20040009613 Methods of identifying modulators of bromodomains |
| 01/15/2004 | US20040009588 Comprises targeted adenoviral expression vector coding antitumor agent; gene therapy; gene expression inhibition |
| 01/15/2004 | US20040009573 Pestalotiopsis microsporia isolates and compounds derived therefrom |
| 01/15/2004 | US20040009510 Single stranded DNA or RNA is enzymatically catalyzing a chemical reaction, cleavaging a predetermined diseased nucleic acid molecule; polymerases |
| 01/15/2004 | US20040009475 Tumor cells to cytotoxic chemotherapeutic agents, especially antimetabolites and agents that damage DNA; excision repair cross-complementing (ERCC1) gene; thymidylate synthase (TS) |
| 01/15/2004 | US20040009464 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmacetical compositions containing such compounds |
| 01/15/2004 | US20040009248 Method for improving the cell protection |
| 01/15/2004 | US20040009244 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 01/15/2004 | US20040009243 Solvent extraction; plant extracts; for use in food and drugs |
| 01/15/2004 | US20040009241 Comprises matrix metalloproteinase/gelatinase inhibitors |
| 01/15/2004 | US20040009239 Use of anoectochilus formosanus plant extracts and their derived fractions as herbal medicines or nutraceutical supplements for chemoprevention or treatment of human malignancies |
| 01/15/2004 | US20040009236 Bowel cleansing composition |
| 01/15/2004 | US20040009235 Hydroxyapatite with specified particle size and a pharmaceutical carrier; osteoporosis; calcium deficiency |
| 01/15/2004 | US20040009234 Gastrointestinal compositions |
| 01/15/2004 | US20040009233 Shark meat extract |
| 01/15/2004 | US20040009232 Dispersion of a liposoluble substance in water in the presence of a surfactant, adding a water soluble polyhydroxylated solid excipient such as mannitol, and granulating; drug delivery of megestrol acetate; excellent water dispersibility |
| 01/15/2004 | US20040009229 Stabilized nanoparticle formulations of camptotheca derivatives |
| 01/15/2004 | US20040009228 Bioabsorbable drug delivery system for local treatment and prevention of infections |
| 01/15/2004 | US20040009225 Contains at least 2 lipidic excipients, one of them being an hydrophilic excipient (having a high HLB value) and the other an oily excipient; stearoyl macroglyceride and soyabean oil for example |
| 01/15/2004 | US20040009224 Obesity controlling method |
| 01/15/2004 | US20040009223 Matrix-forming agent, a bioadhesive, a buffer, and water; for use in the vagina; forms a semisolid matrix on contact with semen and causes hardening of cervical mucus; for STD (sexually transmitted disease) prevention and contraception |
| 01/15/2004 | US20040009222 Processes for forming a drug delivery device |
| 01/15/2004 | US20040009221 Particularly ketorolac; pain treatment; core, a drug layer (which comprises the drug, a binder, and a disintegrant), a protecting layer, and an enteric coating |
| 01/15/2004 | US20040009220 Filler and a release controlling biopolymer such as hydroxypropyl methyl cellulose prepared by a granulation process yielding a quasi-monolithic compact which has a specified erosion time in gastric fluid |
| 01/15/2004 | US20040009217 Therapeutic liposome composition and method |
| 01/15/2004 | US20040009216 Administering liposomes comprising phospholipids and an aqueous layer, said liposomes having specified average diameter; treating various cardiovascular disorders, reducing cholesterol |
| 01/15/2004 | US20040009214 An antianxiety agent such as buspirone; a dermal penetration enhancer of given formula such as octyl salicylate; and a volatile liquid such as ethanol |
| 01/15/2004 | US20040009212 .2-.5% of a mucoadhesive polymer of carboxylvinylpolyester (i.e. carbopol or carbomer) and celluloses, 15%-40% of a thermoresponsive polymer having two critical points and a balance of water |
| 01/15/2004 | US20040009200 Prevention and/or treatment of photoaging of the skin; sunscreen agents |
| 01/15/2004 | US20040009194 Methods, and compositions for a therapeutic antigen presenting cell vaccine for treatment of immunodeficiency virus |
| 01/15/2004 | US20040009185 Enhancing the immune response to an antigen by presensitzing with an inducing agent prior to immunizing with the agent and the antigen |
| 01/15/2004 | US20040009172 Biweekly subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha in combination with another drug which is useful for treating the disorder |
| 01/15/2004 | US20040009169 Administration of agents for the treatment of inflammation |
| 01/15/2004 | US20040009163 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 01/15/2004 | US20040009161 Drug screening from polypeptides and/or proteins coded by allelic genes; genetic engineering |
| 01/15/2004 | US20040009160 Bioactive food complex, method for making bioactive food complex product and method for controlling disease |
| 01/15/2004 | US20040009156 Synergistic mixtures comprising drugs such as cisplatin and cytoplasmic motor proteins, used as anticarcinogenic agents |
| 01/15/2004 | US20040009145 Ionic polymers as toxin-binding agents |
| 01/15/2004 | US20040009144 Method for the treatment or prevention of virus infection using polybiguanide-based compounds |
| 01/15/2004 | US20040009135 Hair growth formulation |
| 01/15/2004 | US20040009126 Inhalation system for prevention and treatment of intracellular infections |
| 01/15/2004 | US20040007689 Freeze-drying, reducing the temperature in the apparatus to bring about freezing and eutectic solidification, reducing the pressure in the apparatus to below the saturation vapour pressure of water over ice, sublimation |
| 01/15/2004 | DE10229070A1 Phenylderivate 5 Phenyl derivatives 5 |
| 01/15/2004 | DE10228090A1 Ausgewählte Anthranylamidpyridinamide und deren Verwendung als Arzneimittel Selected Anthranylamidpyridinamide and their use as medicaments |
| 01/15/2004 | DE10228059A1 Verwendung von amphiphilen Nucleosid-Phosphonoameisensäure-Derivaten zur Behandlung von viralen Infektionskrankheiten Use of amphiphilic nucleoside phosphonoformic acid derivatives for the treatment of viral infectious diseases |
| 01/15/2004 | DE10227938A1 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 01/15/2004 | DE10227935A1 Antibiotische Beschichtung von porösen Körpern und Verfahren zu ihrer Herstellung sowie Verwendung The antibiotic coating of porous bodies and processes for their preparation and use |
| 01/15/2004 | DE10227914A1 Pharmazeutische Zubereitung mit retardierender Wirkstofffreisetzung, Verfahren zu ihrer Herstellung und Verwendung Pharmaceutical formulation having retarded active substance release, methods for their preparation and use |
| 01/15/2004 | DE10227756A1 Biologisches Mittel zur Bekämpfung von Durchfallerkrankungen bei Tieren Biological agents for controlling diarrheal diseases in animals |
| 01/15/2004 | DE10226420A1 Verfahren zur Behandlung der Artherosklerose A method for the treatment of atherosclerosis |
| 01/15/2004 | DE10226326A1 9-alpha-substiuierte Estratriene als selektiv wirksame Estrogene 9-alpha-substiuierte estratrienes as selective estrogens effective |
| 01/15/2004 | DE10204271B4 Verfahren zur Gewinnung von Betulinsäure-Monoethanolat A method for obtaining betulinic acid-Monoethanolat |
| 01/15/2004 | CA2767092A1 Novel compounds, pharmaceutical compositions containing same and methods of use for same |
| 01/15/2004 | CA2531810A1 Compositions and methods for the treatment of parkinson's disease and tardive dyskinesias |
| 01/15/2004 | CA2498049A1 At<sb>1</sb> receptor antagonists for preventing secondary strokes |
| 01/15/2004 | CA2493860A1 Marker genes for determining renal toxicity |
| 01/15/2004 | CA2492535A1 New quinuclidine amide derivatives |
| 01/15/2004 | CA2492278A1 Pharmaceutical composition containing chlorogenic acid analogs for the treatment of chronic myeloid leukaemia |
| 01/15/2004 | CA2492162A1 Hmg-coa reductase inhibitors |
| 01/15/2004 | CA2492122A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 01/15/2004 | CA2492121A1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 01/15/2004 | CA2492037A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 01/15/2004 | CA2492035A1 N-hydroxyamide derivatives possessing antibacterial activity |
| 01/15/2004 | CA2492033A1 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 01/15/2004 | CA2492026A1 New pharmaceutical compositions based on new anticholinergics and pde-iv inhibitors |
| 01/15/2004 | CA2492010A1 Proteins binding to cross-beta structure comprising amyloid and methods for detection and modulation of the cross-beta structure, its formation and its associated toxicity |
| 01/15/2004 | CA2491998A1 Azabicyclo derivatives as muscarinic receptor antagonists |
| 01/15/2004 | CA2491994A1 Modulators of the glucocorticoid receptor |
| 01/15/2004 | CA2491947A1 The use of specified tcf target genes to identify drugs for the treatment of cancer, in particular colorectal cancer, in which tcf/.beta.-catenin/wnt signalling plays a central role |
| 01/15/2004 | CA2491921A1 Hetero-cyclically substituted imidazotriazines |
| 01/15/2004 | CA2491848A1 Pharmaceutical combination of a thromboxane a2 receptor antagonist and a cox-2 inhibitor |
| 01/15/2004 | CA2491835A1 Mch1r antagonists |
| 01/15/2004 | CA2491724A1 Ciclesonide-containing sterile aqueous suspension |
| 01/15/2004 | CA2491712A1 New drug combinations based on magnesium salts and fibrinolytics |
| 01/15/2004 | CA2491710A1 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 01/15/2004 | CA2491685A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising 1,2-prolpylene glycol |
| 01/15/2004 | CA2491682A1 Liquid formulations with a high concentration of human growth hormone (hgh) comprising glycine |
| 01/15/2004 | CA2491673A1 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
| 01/15/2004 | CA2491640A1 Ruthenium anticancer complexes |
| 01/15/2004 | CA2491635A1 Phenyl-[4-(3-phenyl-1h-pyrazol-4-yl)-pyrimidin-2-yl)-amine derivatives |
| 01/15/2004 | CA2491614A1 Compounds and methods for treating cancer and inflammation |
| 01/15/2004 | CA2491573A1 Methods of treating microbial infections in humans and animals |
| 01/15/2004 | CA2491500A1 Substituted imidazotriazines |
| 01/15/2004 | CA2491479A1 Use of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event |
| 01/15/2004 | CA2491478A1 Liquid formulations with high concentration of human growth hormone (hgh) comprising phenol |
| 01/15/2004 | CA2491477A1 Indolin phenylsulfonamide derivatives |
| 01/15/2004 | CA2491474A1 Boroproline compound combination therapy |
| 01/15/2004 | CA2491466A1 Methods and compositions relating to isoleucine boroproline compounds |
| 01/15/2004 | CA2491464A1 Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives |
| 01/15/2004 | CA2491455A1 Novel use of imidazotriazinones |
| 01/15/2004 | CA2491451A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 01/15/2004 | CA2491445A1 Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects |
| 01/15/2004 | CA2491406A1 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 01/15/2004 | CA2491382A1 Compositions comprising panthetine for the treatment of dyslipidemia |
| 01/15/2004 | CA2491372A1 Infertility treatment with exemestane |
| 01/15/2004 | CA2491355A1 Controlled release compositions comprising coated pellets having non-uniform coating thicknesses |
| 01/15/2004 | CA2491286A1 Methods of screening compounds for grk6 modulating activity |
| 01/15/2004 | CA2491257A1 Phospholipid complexes of lexitropsins, their preparation and use in therapeutic formulations |